FRA
ICUI icon

Front Row Advisors’s ICU Medical ICUI Stock Holding History

Front Row Advisors’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15
Closed -$3K – 950
2020
Q2 		$3K Sell
15
-12
-44% -$2.38K ﹤0.01% 761
2020
Q1 		$6K Hold
27
– – ﹤0.01% 575
2019
Q4 		$5K Buy
27
+4
+17% +$688 ﹤0.01% 614
2019
Q3 		$4K Sell
23
-3
-12% -$597 ﹤0.01% 656
2019
Q2 		$7K Hold
26
– – 0.01% 508
2019
Q1 		$6K Buy
26
+7
+37% +$1.68K ﹤0.01% 536
2018
Q4 		$4K Sell
19
-10
-34% -$2.46K ﹤0.01% 593
2018
Q3 		$7 Hold
29
– – ﹤0.01% 488
2018
Q2 		$9 Hold
29
– – 0.01% 469
2018
Q1 		$7K Buy
+29
New +$6.82K ﹤0.01% 493

Other funds holding ICUI

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
NC
Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Front Row Advisors's ICUI Position: Q3 2020 in Review

Front Row Advisors sold out of ICU Medical (ICUI) in Q3 2020, closing a stake of 15 shares — an estimated $3K sold.

Front Row Advisors first reported a position in ICUI in Q1 2018 and held it in 10 quarters. The position peaked at $7K in Q2 2019. 283 funds tracked by Wall St. Rank hold ICUI as of Q3 2020.

  • Front Row Advisors reported no remaining ICU Medical position as of Q3 2020 after selling out during the quarter.
  • Front Row Advisors sold 15 ICU Medical shares in Q3 2020, an estimated $3K.
  • Front Row Advisors first reported a position in ICU Medical in Q1 2018 and held it in 10 quarters.
  • Front Row Advisors's ICU Medical position peaked at $7K in Q2 2019.
  • 283 funds tracked by Wall St. Rank held ICU Medical as of Q3 2020.

Based on Front Row Advisors's 13F filing for Q3 2020, filed 30 Nov 2020.